KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest ExpensesInterest ExpensesNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Clorox (CLX) Shares Outstanding (Weighted Average) (2016 - 2026)

Clorox has reported Shares Outstanding (Weighted Average) over the past 18 years, most recently at $121.4 million for Q1 2026.

  • For Q1 2026, Shares Outstanding (Weighted Average) fell 1.62% year-over-year to $121.4 million; the TTM value through Mar 2026 reached $121.4 million, down 1.62%, while the annual FY2025 figure was $123.5 million, 0.52% down from the prior year.
  • Shares Outstanding (Weighted Average) for Q1 2026 was $121.4 million at Clorox, roughly flat from $121.6 million in the prior quarter.
  • Over five years, Shares Outstanding (Weighted Average) peaked at $124.2 million in Q4 2023 and troughed at $121.4 million in Q1 2026.
  • A 5-year average of $123.3 million and a median of $123.5 million in 2025 define the central range for Shares Outstanding (Weighted Average).
  • Biggest five-year swings in Shares Outstanding (Weighted Average): decreased 2.28% in 2022 and later rose 0.51% in 2023.
  • Year by year, Shares Outstanding (Weighted Average) stood at $123.5 million in 2022, then grew by 0.51% to $124.2 million in 2023, then decreased by 0.32% to $123.8 million in 2024, then fell by 1.76% to $121.6 million in 2025, then decreased by 0.2% to $121.4 million in 2026.
  • Business Quant data shows Shares Outstanding (Weighted Average) for CLX at $121.4 million in Q1 2026, $121.6 million in Q4 2025, and $122.6 million in Q3 2025.